TP53 and cancer: For example, cancer cells transport P53 to the cytoplasm through the CRM1-mediated output mechanism to escape the apoptotic effect of P53 (Haggag et al., 2020), resulting in decreased cytotoxicity of drugs such as doxorubicin.